|
|
||||||||
Original Articles |
The term "acute interstitial pneumonia" (AIP) describes an idiopathic clinicopathological condition, characterized clinically by an interstitial lung disease causing rapid onset of respiratory failure, which is distinguishable from the other more chronic forms of interstitial pneumonia. It is synonymous with Hamman-Rich syndrome, occurring in patients without pre-existing lung disease. The histopathological findings are those of diffuse alveolar damage. AIP radiologically and physiologically resembles acute respiratory distress syndrome (ARDS) and is considered to represent the small subset of patients with idiopathic ARDS. It is frequently confused with other clinical entities characterized by rapidly progressive interstitial pneumonia, especially secondary acute interstitial pneumonia, acute exacerbations and accelerated forms of cryptogenic fibrosing alveolitis . Furthermore, many authors use the above terms, both erroneously and interchangeably. It has a grave prognosis with >70% mortality in 3 months, despite mechanical ventilation. This review aims to clarify the relative clinical and pathological issues and terminology.
This article has been cited by other articles:
![]() |
I-N. Park, D. S. Kim, T. S. Shim, C.-M. Lim, S. D. Lee, Y. Koh, W. S. Kim, W. D. Kim, S. J. Jang, and T. V. Colby Acute Exacerbation of Interstitial Pneumonia Other Than Idiopathic Pulmonary Fibrosis Chest, July 1, 2007; 132(1): 214 - 220. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Parambil, J. L. Myers, and J. H. Ryu Diffuse alveolar damage: uncommon manifestation of pulmonary involvement in patients with connective tissue diseases. Chest, August 1, 2006; 130(2): 553 - 558. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Inayama, Y. Nishioka, M. Azuma, S. Muto, Y. Aono, H. Makino, K. Tani, H. Uehara, K. Izumi, A. Itai, et al. A Novel I{kappa}B Kinase-beta Inhibitor Ameliorates Bleomycin-induced Pulmonary Fibrosis in Mice Am. J. Respir. Crit. Care Med., May 1, 2006; 173(9): 1016 - 1022. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Y. Suh, E. H. Kang, M. P. Chung, K. S. Lee, J. Han, M. Kitaichi, and O J. Kwon Early Intervention Can Improve Clinical Outcome of Acute Interstitial Pneumonia Chest, March 1, 2006; 129(3): 753 - 761. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Quefatieh, C. H. Stone, B. DiGiovine, G. B. Toews, and R. C. Hyzy Low Hospital Mortality in Patients With Acute Interstitial Pneumonia Chest, August 1, 2003; 124(2): 554 - 559. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Kumar, P. Goldstraw, K. Yamada, A. G. Nicholson, A. U. Wells, D. M. Hansell, R. M. duBois, and G. Ladas Pulmonary fibrosis and lung cancer: Risk and benefit analysis of pulmonary resection J. Thorac. Cardiovasc. Surg., June 1, 2003; 125(6): 1321 - 1327. [Abstract] [Full Text] |
||||
![]() |
A. Bonaccorsi, A. Cancellieri, M. Chilosi, R. Trisolini, M. Boaron, N. Crimi, and V. Poletti Acute interstitial pneumonia: report of a series Eur. Respir. J., January 1, 2003; 21(1): 187 - 191. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. N. Gong and E. J. Mark Case 40-2002 - A 56-Year-Old Man with Rapidly Worsening Dyspnea N. Engl. J. Med., December 26, 2002; 347(26): 2149 - 2157. [Full Text] [PDF] |
||||
![]() |
F. Philit, B. Etienne-Mastroianni, A. Parrot, C. Guerin, D. Robert, and J.-F. Cordier Idiopathic Acute Eosinophilic Pneumonia: A Study of 22 Patients Am. J. Respir. Crit. Care Med., November 1, 2002; 166(9): 1235 - 1239. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ichikado, M. Suga, N. L. Muller, H. Taniguchi, Y. Kondoh, M. Akira, T. Johkoh, N. Mihara, H. Nakamura, M. Takahashi, et al. Acute Interstitial Pneumonia: Comparison of High-Resolution Computed Tomography Findings between Survivors and Nonsurvivors Am. J. Respir. Crit. Care Med., June 1, 2002; 165(11): 1551 - 1556. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Okamoto, S. Kato, K. Oizumi, M. Kinoshita, Y. Inoue, K. Hoshino, S. Akira, A. N. J. Mckenzie, H. A. Young, and T. Hoshino Interleukin 18 (IL-18) in synergy with IL-2 induces lethal lung injury in mice: a potential role for cytokines, chemokines, and natural killer cells in the pathogenesis of interstitial pneumonia Blood, February 15, 2002; 99(4): 1289 - 1298. [Abstract] [Full Text] [PDF] |
||||
![]() |
American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias . This Joint Statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS Board of Directors, June 2001 and by The ERS Executive Committee, June 2001 Am. J. Respir. Crit. Care Med., January 15, 2002; 165(2): 277 - 304. [Full Text] [PDF] |
||||
![]() |
A Shaw Multiple-choice questionnaire: general Imaging, December 31, 2001; 13(6): 488 - 494. [Full Text] [PDF] |
||||
![]() |
M. Demedts, A.U. Wells, J.M. Anto, U. Costabel, R. Hubbard, P. Cullinan, H. Slabbynck, G. Rizzato, V. Poletti, E.K. Verbeken, et al. Interstitial lung diseases: an epidemiological overview Eur. Respir. J., July 1, 2001; 18(32_suppl): 2S - 16s. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |